The entertainment industry is a curious market. It trades in emotion, spinning narratives into gold. But every so often, a headline lands that defies any balance sheet logic. The death of Daveigh Chase, the actress best known for her chilling turn in *The Ring* and her voice work in *Lilo & Stitch*, at 24 from AIDS-related complications, is one such event. The UK entertainment sector has paused to honour her, but the real story lies beneath the tributes, in the grim calculus of lost potential and the costs of a disease we have stubbornly failed to price out of existence.
Let us first address the raw economics of celebrity. Chase was a rare asset: a child star who had successfully transitioned to adult roles, with a portfolio that included both blockbuster horror and beloved animation. Her death at such a young age represents a catastrophic loss of future earnings. Had she continued her trajectory, she might have commanded seven-figure paychecks per film, endorsements and a lasting brand. Instead, her estate is left to manage the residuals of a truncated career. The Hollywood machine will move on, but the present value of her future income stream has been permanently written down to zero.
More troubling is the context. AIDS is not a disease of the 1980s. It persists, a stubborn drag on global health budgets and human capital. The fact that a young, successful American actress could die of it in 2023 speaks to a systemic failure. In the UK, the NHS spends roughly £20 million annually on HIV prevention and treatment. Yet globally, the market for HIV prevention is distorted. Governments underinvest, private insurers hesitate and pharmaceutical patents keep prices high. The result is a tragedy of the commons where a preventable disease continues to claim lives like Chase’s.
The tributes from the UK entertainment industry are predictable: candles lit, social media posts, obituaries in the *Guardian*. But compare this to the fiscal response. The government’s latest budget allocated an extra £2.3 billion to the NHS, but only a fraction will go to sexual health services. Meanwhile, the creative industries contribute over £100 billion to the UK economy. It would be a simple hedge to invest a fraction of that in the health of its workforce. But we don’t. We prefer to honour the dead rather than prevent the deaths.
This is the bitter lesson of Daveigh Chase’s passing. The markets have already priced in her loss. Gilt yields barely flickered. No derivatives were triggered. The capital markets are indifferent. It is left to us, the editorial class, to assign value where the invisible hand does not reach. We can choose to see her life as a warning: that even in a world of medical miracles, complacency carries a cost. Or we can light another candle and watch the wax burn down, a symbol of our collective failure to allocate resources where they are needed most.
Rest in peace, Ms. Chase. The bottom line on your life was not your box office gross but the lives you might have saved if we had listened. The UK honours you, but the market has no memory.
